Showing articles with keyword: translational research | CLEAR
August 27, 2018
CTSI-Supported Researchers Helping Veterans with PTSD
Dr. Maggie O’Haire of Purdue University and Jason Snodgrass of K9s For Warriors (Photo courtesy of ConsumerAdvocate.org)
The work of Indiana CTSI-supported researchers was recently highlighted in a ConsumerAdvocate.org story about the K9s For Warriors program, which recently partnered with Purdue University to study the effectiveness of service dogs as a complementary treatment for military members and veterans who suffer from PTSD.
The study was led by Purdue’s Maggie O’Haire, PhD, an assistant professor of human-animal interaction in the Purdue College of Veterinary Medicine, and Kerri Rodriguez, a human-animal interaction graduate student in the school. Dr. O’Haire is a 2016-2018 recipient of the Indiana...
August 15, 2018
CTSI Welcomes New Associate Director for Technology and Innovation
The Indiana Clinical and Translational Sciences Institute’s (CTSI) expert leadership team is growing, mostly recently with the addition of prolific regenerative medicine researcher Chandan Sen, PhD.
Chandan Sen, PhD (Photo by IU School of Medicine)
Dr. Sen was recently recruited to IU School of Medicine from The Ohio State University. At IU, he will serve as inaugural director of the Indiana Center for Regenerative Medicine and Engineering effective August 15. Dr. Sen brings with him more than $10 million in research grants and a team of more than 30 scientists and staff who will study how to tap into the power of regenerative...
August 2, 2018
Indiana CTSI Annual Meeting to Celebrate 10 Years, Focus on Gene Therapy Research
Faculty and staff researchers, students and the public are invited to celebrate the 10th anniversary of the Indiana Clinical and Translational Sciences Institute (CTSI) at its 2018 Annual Meeting on Friday, September 14, at Hine Hall on the IUPUI campus in Indianapolis.
Researchers present posters at the Indiana CTSI’s 2017 Annual Meeting.
Founded in 2008, the Indiana CTSI brings together the state’s brightest minds to solve Indiana’s most pressing health challenges through research. The institute is a statewide partnership among Indiana University, Purdue University, the University of Notre Dame and numerous life sciences businesses, government entities and community organizations.
This year’s Annual...
August 2, 2018
Indiana CTSI to Host Mock Study Section at National Translational Science Conference
By Ashlynn Neumeyer:
The Indiana Clinical and Translational Sciences Institute (CTSI) will host the Association for Clinical and Translational Sciences (ACTS) Mock Study Section for the next three years, debuting in March 2019. The goal of the ACTS meeting is to support and advance translational science, or the translation of research and discoveries in the lab into therapies and solutions that improve human health.
The Mock Study Section is a formal workshop that replicates for participants the review process for how the National Institutes of Health (NIH) decides which grant applications will be funded. During the event, scientific review officers and...
May 21, 2018
Three Decades of Research Culminates in FDA Drug Approval
By IU School of Medicine and CTSI Staff Reports:
Indiana CTSI-supported research led by two Indiana University School of Medicine faculty members has culminated in U.S. Food and Drug Administration approval of a new drug for patients with an uncommon, painful and deforming bone disease.
IU School of Medicine researchers Michael Econs and Kenneth White (Photo courtesy of Indiana University)
The drug, burosumab, treats X-linked hypophosphatemia, or XLH. It is being brought to market by Ultragenyx Pharmaceutical Inc. in collaboration with Kyowa Hakko Kirin Co., Ltd. and its European subsidiary, Kyowa Kirin International PLC, under the brand name Crysvita.
XLH is a phosphate-wasting disease that...
April 26, 2018
CTSI-Supported Researchers Identify ‘Key’ Molecule in Parkinson’s Disease
By Steve Tally:
A molecule has been identified that appears to play an important role in the development of Parkinson’s disease, a debilitating disease that affects millions of people around the world.
A key factor in the development of Parkinson’s disease has been identified by a team of researchers at Purdue University. Jean-Christophe (Chris) Rochet, professor in the Department of Medicinal Chemistry and Molecular Pharmacology in the College of Pharmacy (left) and Dr. Riyi Shi, professor in the Department of Basic Medical Sciences, College of Veterinary Medicine and Weldon School of Biomedical Engineering. (Purdue University photo by Alex Kumar)
The discovery could lead...
March 1, 2017
Applications sought for summer undergraduate research interns
The Indiana Clinical and Translational Sciences Institute is accepting applications for summer interns as part of its undergraduate clinical and translational research program, which provides undergraduate students with the opportunity to work with Indiana CTSI mentors on projects designed to increase their awareness of and interest in translational research.
The program is geared toward students who are keenly interested in research. However, in addition to conducting research, program activities will include training and workshops focused on developing skills in public speaking, writing, presentation preparation, how to deal with personal issues in postgraduate training and academic environments, research ethics, interviewing and...